Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia

Blood. 1983 Dec;62(6):1242-50.

Abstract

A family with a high incidence of spontaneous thromboembolism over four generations has been investigated. The propositus is a 21-yr-old male with a history of thrombophlebitis. Medical histories of 46 family members were obtained. Twelve of these individuals have experienced deep venous thromboses and/or pulmonary emboli. Seven members of the kindred, with a prior history of thrombotic phenomena, were investigated in detail. These subjects were found to have normal plasma concentrations of immunoreactive antithrombin (mean 96%), decreased plasma levels of progressive antithrombin activity (mean 50%), and greatly reduced amounts of plasma heparin cofactor activity (mean 42%). The abnormal antithrombin ("Chicago") was found to elute from heparin-Sepharose at a higher ionic strength than normal inhibitor. The functionally defective antithrombin molecules exhibit a reduced ability to neutralize thrombin in the presence or absence of heparin (approximately 10%-20% of normal). The molecular defect of this protease inhibitor thus appears to be distinct from those of previously described abnormal antithrombins.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antithrombin III / analysis
  • Antithrombin III / genetics*
  • Antithrombin III / metabolism
  • Blood Coagulation Tests
  • Chromatography, Affinity
  • Female
  • Heparin / metabolism*
  • Humans
  • Male
  • Pedigree
  • Plasminogen / analysis
  • Plasminogen / genetics
  • Thromboembolism / blood*
  • Thromboembolism / diagnosis
  • Thromboembolism / genetics
  • Thrombosis / blood
  • Thrombosis / genetics

Substances

  • Antithrombin III
  • Plasminogen
  • Heparin